Genetics of sporadic ALS

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

Volumn 2, Issue SUPPL. 1, 2001, Pages 37-41

  Andersen, Peter M ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ALS; CuZn SOD; Recessive inheritance; Reduced disease penetrance

Indexed keywords

APOLIPOPROTEIN E; COPPER ZINC SUPEROXIDE DISMUTASE; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; GLUTAMIC ACID; LYSINE; MANGANESE SUPEROXIDE DISMUTASE; NEUROFILAMENT PROTEIN; PROLINE; SERINE;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOMINANT INHERITANCE; FAMILIAL DISEASE; FEMALE; GENDER; GENE MUTATION; GENETIC EPIDEMIOLOGY; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HETEROZYGOSITY; HUMAN; MALE; MORTALITY; NEUROFILAMENT; PEDIGREE ANALYSIS; PRIORITY JOURNAL; RECESSIVE INHERITANCE; RISK FACTOR;

EID: 0035020730     PISSN: 14660822     EISSN: None     Source Type: Journal    
DOI: 10.1080/14660820152415726     Document Type: Article

References (63)

1. Riggs JE. Longitudinal Gompertzian analysis of amyotrophic lateral sderosis mortality in the US, 1977-1986. Evidence for an inherently susceptible subset. Mech Ageing Dev 1990; 55: 207.
2. Neilson S, Robinson I, Hunter M. Longitudinal Gompertzian analysis of ALS mortality in England and Wales, 1963-1989: estimate of susceptibility in the general population. Mech Ageing Dev 1992; 64: 201-216.
3. Neilson S, Robinson I, Nymoen EH. Longitudinal analysis of amyotrophic lateral sclerosis mortality in Norway, 1966-1989: evidence for a susceptible subpopulation. J Neurol Sci 1994; 122: 148-154.
4. Neilson S, Gunnarsson LG, Robinson I. Rising mortality from motor neurone disease in Sweden 1961-1990: the relative role of increased population life expectancy and environmental factors. Acta Neurol Scand 1994; 3: 150-159.
5. Neilson S, Robinson I, Alperovitch A. Rising amyotrophic lateral sclerosis mortality in France 1968-1990: increased life expectancy and inter-disease competition as an explanation. J Neurol 1994; 241: 448-455.
6. Neilson S, Robinson I, de Pedro-Cuesta J, Veiga-Cabo J. Decline and rise of mortality from motor neuron disease in Spain 1960-1989: demographic, environmental and competitive influences. Neuroepidemiol 1996; 15: 180-191.
7. Hawkes CH, Graham AJ. National UK motor neuron disease twin study using the death discordant approach. Ann Neurol 1992; 32: 272-273.
8. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Brain 1995; 118: 707-719.
9. Kristensen O, Melgaard B. Motor neuron disease. Prognosis and epidemiology. Acta Neurol Scand 1977; 56: 299-308.
10. Cudkowicz ME, McKenna-Vasek D, Sapp PE et al. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol 1997; 2: 210-221.
11. Al-Chalabi A, Enayat ZE, Bakker MC et al. Association of apolipoprotein E ε4 allele with bulbar-onset motor neuron disease. Lancet 1996; 347: 159-160.
12. Moulard B, Sefiani A, Laamri A, Malafosse A, Camu W. Apolipoprotein E genotyping in sporadic amyotrophic lateral sclerosis: evidence for a major influence on the clinical presentation and prognosis. J Neurol Sci 1996; 139 (Suppl): 34-37.
13. Mui S, Rebeck GW, McKenna-Yasek D, Hyman BT, Brown RH. Apolipoprotein E ε4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis. Ann Neurol 1995; 38: 460-463.
14. Smith RG, Haverkamp LJ, Case S, Appel V, Appel SH. Apolipoprotein E ε4 in bulbar-onset motor neuron disease. Lancet 1996; 348: 334-335.
15. Tomblyn M, Kasarskis EJ, Xu Y, St Clair DK. Distribution of MnSOD polymorphisms in sporadic ALS patients. J Mol Neurosci 1998; 1: 65-66.
16. Van Landeghem GF, Tabatabaie P, Beckman L, Beckman G, Andersen PM. Mn-SOD signal sequence polymorphism associated with sporadic motor neuron disease. Eur J Neurol 1999; 6: 639-644.
17. Kisby GE, Milne J, Sweet C. Evidence of reduced DNA repair in amyotrophic lateral sclerosis brain tissue. NeuroReport 1997; 8: 1337-1340.
18. Hayward C, Colville S, Swingler RJ, Brock DJH. Molecular genetic analysis of the APEX nuclease gene in amyotrophic lateral sclerosis. Neurology 1999; 52: 1899-1901.
19. Olkowski ZL Mutant AP endonuclease in patients with amyotrophic lateral sclerosis. NeuroReport 1998; 9: 239-242.
20. Figlewicz DA, Krizus A, Martinoli MG et al. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet 1994; 3: 1757-1761.
21. Al-Chalabi A, Andersen PM, Chioza B et al. Recessive amyotrophic lateral sclerosis with the D90A SOD1 mutation shares a common founder: evidence for a linked protective factor. Hum Mol Genet 1998; 13: 2045-2050.
22. Tomkins J, Usher P, Slade JY et al. Novel NF-H insertion in ALS. NeuroReport 1998; 9: 3967-3970.
23. Vechio JD, Bruijn LI, Xu Z, Brown RH Jr, Cleveland D. Sequence variants in human neurofilament proteins: absence of linkage to familial amyotrophic lateral sclerosis. Ann Neurol 1996; 40: 603-610.
24. Rooke K, Figlewicz DA, Han FY, Rouleau GA. Analysis of the KSP repeat of the neurofilament heavy subunit in familial amyotrophic lateral sclerosis. Neurology 1996; 46: 789-790.
25. Orrell RW, Marklund SL, de Belleroche JS. Familial ALS is associated with mutations in all exons of SOD1: a novel mutation in exon 3 (Gly72Ser). J Neurol Sci 1997; 153: 46-49.
26. Moulard B, Salachas F, Chassande B et al. Association between centromeric deletions of the SMN gene and sporadic adult-onset lower motor neuron disease. Ann Neurol 1998; 5: 640-644.
27. Parboosingh JS, Meininger V, McKenna-Yasek D, Brown RH Jr, Rouleau G. Deletions causing spinal muscular atrophy do not predispose to amyotrophic lateral sclerosis. Arch Neurol 1999; 56: 710-712.
28. Jackson M, Morrison KE, Al-Chalabi A, Bakker M, Leigh PN. Analysis of chromosome 5q13 genes in amyotrophic lateral sclerosis: homozygous NAIP deletion in a sporadic case. Ann Neurol 1996; 39: 796-800.
29. Mitsumoto H, Sliman RJ, Schafer IA et al. Motor neuron disease and adult hexosaminidase A deficiency in two families: evidence for multisystem degeneration. Ann Neurol 1985; 4: 378-385.
30. Hancock LW, Horwitz AL, Cashman NR, Antel JP, Dawson G. N-acetyl-beta-hexosaminidase B defiency in cultured fibroblasts from a patient with progressive motor neuron disease. Biochem Biophys Res Commun 1985; 3: 1185-1192.
31. Cashman NR, Antel JP, Hancock LW et al. N-acetyl-beta-hexosaminidase beta locus defect and juvenile motor neuron disease: a case study. Ann Neurol 1986; 6: 568-572.
32. Rubin M, Karpati G, Wolfe LS, Carpenter S, Klavins MH, Mahuran DJ. Adult onset motor neuronopathy in the juvenile type of hexosaminidase and B deficiency. J Neurol Sci 1988; 1: 103-119.
33. Mondelli M, Rossi A, Palmeri S, Rizzuto N, Federico A. Neurophysiological study in chronic GM2 gangliosidosis (hexosaminidase A and B deficiency), with motor neuron disease phenotype. Ital J Neurol Sci 1989; 4: 433-439.
34. Banerjee P, Siciliano L, Oliveri D et al. Molecular basis of an adult form of beta-hexosaminidase B deficiency with motor neuron disease. Biochem Biophys Res Commun 1991; 1: 108-115.
35. Le Coz P, Assouline E, Vanier MT et al. GM2-Gangliosidosis variant B1 disclosed during adolescence by an isolated multi-systemic involvement of the central and peripheral nervous systems. Rev Neurol (Paris) 1994; 1: 61-66.
36. Aoki M, Lin Cl, Rothstein JD et al. Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis. Ann Neurol 1998; 5: 645-653.
37. Meyer T, Munch C, Volkel H, Booms P, Ludolph AC. The EAAT2 (GLT-1) gene in motor neuron disease: absence of mutations in amyotrophic lateral sclerosis and a point mutation in patients with hereditary spastic paraplegia. J Neurol Neurosurg Psychiatry 1998; 4: 594-596.
38. Comi GP, Bordoni A, Salani S et al. Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron disease. Ann Neurol 1998; 43: 110-116.
39. Rosen DR, Siddique T, Patterson D et al. Mutations in CuZn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59-62.
40. Andersen PM, Morita M, Brown RH, Jr. Genetics of amyotrophic lateral sclerosis: an overview. In: RH Brown Jr, V Meininger, M Swash, eds. Amyotrophic Lateral Sclerosis. Martin Dunitz, London, 1999.
41. Andersen PM, Nilsson P, Ala-Hurula V et al. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nat Genet 1995; 10: 61-66.
42. Andersen PM, Forsgren L, Binzer M et al. Autosomal recessive adult-onset ALS associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients. Brain 1996; 119: 1153-1172.
43. Al-Chalabi A, Andersen PM, Nilsson P et al. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum Mol Genet 1999; 8:157-164.
44. Robberecht W, Aguirre T, Bosch LVD, Tilkin P, Cassiman JJ, Matthijs G. D90A heterozygosity in the SOD1 gene is associated with familial and apparantly sporadic amyotrophic lateral sclerosis. Neurology 1996; 47: 1336-1339.
45. Boukaftane Y, Khoris J, Moulard B. et al. Identification of six novel SOD1 gene mutations in familial amyotrophic lateral sclerosis. Can J Neurol Sci 1998; 25: 192-196.
46. Jackson M, Al-Chalabi A, Enayat ZE, Chioza B, Leigh PN, Morrison KE. Copper/zinc superoxide dismutase 1 and sporadic amyotrophic lateral sclerosis: analysis of 155 cases and identification of a novel insertion mutation. Ann Neurol 1997; 42: 803-807.
47. Radunovič A, Leigh PN. CuZn superoxide dismutase gene mutations in ALS. Correlation between genotype and clinical features. J Neurol Neurosurg Psychiatry 1996; 61: 565-572.
48. Andersen PM, Nilsson P, Keränen M-L et al. Phenotypic heterogeneity in MND-patients with CuZn-superoxide dismutase mutations in Scandinavia. Brain 1997; 10: 1723-1737.
49. Suthers G, Laing N, Wilton S, Dorosz S, Waddy H. "Sporadic" motoneuron disease due to familial SOD1 mutation with low penetrance. Lancet 1994; 344: 1773.
50. Jones CT, Swingler RJ, Simpson SA, Brock DJH. Superoxide dismutase mutations in an unselected cohort of Scottish amyotrophic lateral sclerosis patients. J Med Genet 1995; 32: 290-292.
51. Getzoff EED, Tainer JA, Stempien MM, Bell GI, Hallewell RA. Evolution of CuZn superoxide dismutase and the Greek key beta-barrel structural motif. Proteins 1989; 5: 322-336.
52. Deng H-X, Hentati A, Tainer JA et al. Amyotrophic lateral sclerosis and structural defects in CuZn superoxide dismutase. Science 1993; 261: 1047-1051.
53. Hayashi K, Yandell DW. How sensitive is PCR-SSCP? Hum Mutat 1993; 2: 338-346.
54. Shaw CE, Enayat ZE, Chioza BA et al. Mutations in all five exons of SOD-1 may cause ALS. Ann Neurol 1998; 43: 390-394.
55. Jones CT, Swingler RJ, Brock DJH. Identification of a novel SOD1 mutation in an apparently sporadic amyotrophic lateral sclerosis patient and the detection of Ile113Thr in three others. Hum Mol Genet 1994; 3: 649-650.
56. Orrell RW, Habgood JJ, de Belleroche JS, Lane RJ. The relationship of spinal muscular atrophy to motor neuron disease: investigation of SMN and NAIP gene deletions in sporadic and familial ALS. J Neurol Sci 1997; 1: 55-61.
57. Kawamata J, Shimohama S, Takano S et al. Novel G16S (GGC-AGC) mutation in the SOD-1 gene in a patient with apparently sporadic young-onset amyotrophic lateral sclerosis. Hum Mutat 1997; 9: 356-358.
58. Riggio MC, Botti S, Gellera C et al. SOD1 gene: molecular screening in amyotrophic lateral sclerosis Italian families. Abstract, European Neurological Society Conference, Milan, Italy, June 1999.
59. Mezei M, Andersen PM, Stewart H, Weber M, Eisen A. Motor system abnormalities in heterozygous relatives of a D90A homozygous CuZn-SOD ALS patient of Finnish extraction. J Neurol Sci 1999; 169: 49-55.
60. Jones CT, Shaw PJ, Chari G, Brock DJH. Identification of a novel exon 4 SOD1 mutation in a sporadic amyotrophic lateral sclerosis patient. Mol Cellul Probes 1994; 8: 329-330.
61. Shimizu T, Kawata A, Kato S et al. Autonomic failure in ALS with a novel SOD1 gene mutation. Neurology 2000; 54: 1534-1537.
62. Hosler BA, Nicholson GA, Sapp PC et al. Three novel mutations and two variants in the gene for Cu/Zn superoxide dismutase in familial amyotrophic lateral sclerosis. Neuromusc Disord 1996; 6: 361-366.
63. Skvortsova VL, Limborskaya SA, Slominsky PA et al. Sporadic amytrophic lateral sclerosis associated with Asp90Ala CuZn-superoxide dismutase mutations in Russia (text in Russian). J Neurology Psychiatry 2000; 100: 44-47.